TCHELET, AMIR,HAYDEN, MICHAEL,HAYARDENY, LIAT,ROSS, COLIN JAMES DOUGLAS,GROSSMAN, IRIS,LADKANI, DAVID,TCHELET, Amir,HAYDEN, Michael,HAYARDENY, Liat,ROSS, Colin, James Douglas,GROSSMAN, Iris,LADKANI, David
申请号：
CA2926724
公开号：
CA2926724A1
申请日:
2014.10.21
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype corresponding to the nucleotide polymorphisms consisting of: Group 1, of the subject at a location location of one or more single (SNPs) selected from the group.
